glp-1 news today 2025 october 9 Weighty issue: drugs are reshaping packaging demand Who Gets the Shot? GLP-1

By purchasing this product, the buyer acknowledges that it is a research material and agrees to use it solely for lawful laboratory and scientific research purposes

Additionally, severe renal impairment, active pancreatitis, or diabetic retinopathy complications require careful provider evaluation

Acknowledgements This work was supported by the Medical Research Council [grant numbers MR/J01186X/1, G0901321, MR/M006301/1], (the third grant is a UK New Investigator Research Grant supporting MJB)

Interestingly, inhibiting WNT1-expressing spinal afferents increases food intake [37], suggesting a physiological role for this sensory cell type in suppressing food intake

Given the widespread use of GLP-1 medications for weight management and diabetes, the findings could have significant public health implications

Discover how microdosing unlocks a safer, more sustainable approach